Smartleaf Asset Management’s Health Catalyst HCAT Stock Holding History

Smartleaf Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.76K	Hold	1,918	–	–	﹤0.01%	2773
2026 Q1	$2.26K	Buy	1,918 +570	+42%	+$1.07K	﹤0.01%	2925
2025 Q4	$3.21K	Buy	1,348 +622	+86%	+$1.7K	﹤0.01%	2840
2025 Q3	$2.12K	Buy	726 +549	+310%	+$1.88K	﹤0.01%	2604
2025 Q2	$674	Sell	177 -247	-58%	-$972	﹤0.01%	2545
2025 Q1	$1.93K	Sell	424 -47	-10%	-$249	﹤0.01%	2480
2024 Q4	$3.3K	Sell	471 -460	-49%	-$3.66K	﹤0.01%	2384
2024 Q3	$7.74K	Buy	931 +884	+1,881%	+$6.39K	﹤0.01%	1910
2024 Q2	$284	Buy	+47	New	+$302	﹤0.01%	2639

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Smartleaf Asset Management's HCAT Position: Q2 2026 in Review

Smartleaf Asset Management held its Health Catalyst (HCAT) position steady in Q2 2026 at 1,918 shares worth $3.76K. The position accounts for ﹤0.01% of the portfolio, ranked #2773.

Smartleaf Asset Management first reported a position in HCAT in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.74K in Q3 2024. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

Smartleaf Asset Management held 1,918 shares of Health Catalyst worth $3.76K as of Q2 2026.
Smartleaf Asset Management left its Health Catalyst share count unchanged in Q2 2026.
Health Catalyst made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2773 holding.
Smartleaf Asset Management first reported a position in Health Catalyst in Q2 2024 and has held it in 9 quarters since.
Smartleaf Asset Management's Health Catalyst position peaked at $7.74K in Q3 2024.
126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.